Data / Drug companies / Radioactive Diagnostic Agent
Radioactive Diagnostic Agent drugs: 31 drugs from 42 companies in the FDA NDC directory
Radioactive Diagnostic Agent is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 81 products in this class from 42 companies, covering 31 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on July 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 42Companies
- 81Products
- 31Drugs by generic name
Drugs in the Radioactive Diagnostic Agent class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Fludeoxyglucose f-18 | 14 | 13 |
| Ammonia n-13 | 13 | 13 |
| Fludeoxyglucose f18 | 7 | 7 |
| Sodium fluoride f-18 | 6 | 6 |
| Fludeoxyglucose f 18 | 4 | 4 |
| Nh3n13 | 4 | 4 |
| Sodium fluoride f 18 | 4 | 4 |
| Ammonia n 13 | 2 | 2 |
| Gallium ga-68 gozetotide | 2 | 2 |
| Ioflupane i-123 | 2 | 2 |
| Piflufolastat f-18 | 2 | 2 |
| Technetium tc 99m medronate | 1 | 2 |
| Technetium tc 99m sestamibi | 1 | 2 |
| Choline c-11 | 1 | 1 |
| Copper cu 64 dotatate | 1 | 1 |
| Florbetaben f 18 | 1 | 1 |
| Florbetapir f 18 | 1 | 1 |
| Flotufolastat f-18 | 1 | 1 |
| Fluciclovine f-18 | 1 | 1 |
| Fluoroestradiol f 18 | 1 | 1 |
| Flurpiridaz f-18 | 1 | 1 |
| Flutemetamol f-18 | 1 | 1 |
| Kit for the preparation of technetium tc99m sestamibi | 1 | 1 |
| Rubidium chloride rb-82 | 1 | 1 |
| Rubidium rb 82 | 1 | 1 |
| Sodium fluoride f18 | 1 | 1 |
| Sodium iothalamate i-125 injection | 1 | 1 |
| Tc 99m medronate | 1 | 1 |
| Technetium tc-99m exametazime | 1 | 1 |
| Technetium tc99m pyrophosphate | 1 | 1 |
| Thallous chloride, tl 201 | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Cardinal Health 414, LLC | 5 | injection; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 1, 2020 |
| Biomedical Research Foundation of Northwest Louisiana | 4 | injection, solution | Generic drugs (ANDA) | May 14, 2015 |
| Mayo Clinic | 4 | injection; injection, solution | Generic drugs (ANDA) | August 5, 2013 |
| 3D Imaging Drug Design and Development LLC | 3 | injection | Generic drugs (ANDA) | January 2, 2012 |
| Curium US LLC | 3 | injection, solution | New drug applications (NDA) | March 31, 2022 |
| Kreitchman Pet Center | 3 | injection | Generic drugs (ANDA) | May 23, 2016 |
| Medi-Physics Inc. DBA GE Healthcare | 3 | solution; injection, solution | New drug applications (NDA) | January 1, 2014 |
| Petnet Solutions, Inc. | 3 | injection, solution; injection | Generic drugs (ANDA) | January 26, 2011 |
| Precision Nuclear LLC | 3 | injection, solution; injection | Generic drugs (ANDA) | January 1, 2011 |
| Sofie Co. | 3 | injection | Generic drugs (ANDA) | December 8, 2011 |
| The Feinstein Institutes for Medical Research | 3 | injection | New drug applications (NDA) | November 19, 2014 |
| Ucsf Radiopharmaceutical Facility | 3 | injection; injection, solution | Generic drugs (ANDA) | December 14, 2020 |
| Bamf Health Inc. | 2 | injection | Generic drugs (ANDA) | March 11, 2025 |
| Blue Earth Diagnostics | 2 | injection; injection, solution | New drug applications (NDA) | May 25, 2023 |
| Brigham and Women's Hospital, Inc., The | 2 | injection | Generic drugs (ANDA) | November 1, 2014 |
| Ionetix Corporation | 2 | injection; injection, solution | Generic drugs (ANDA) | January 17, 2024 |
| Jubilant DraxImage Inc., DBA Jubilant Radiopharma | 2 | injection, solution; injection, powder, lyophilized, for solution | New drug applications (NDA) | August 17, 2017 |
| Massachusetts General Hospital | 2 | injection, solution | Generic drugs (ANDA) | February 3, 2016 |
| Sofie Co. DBA Sofie | 2 | injection | Generic drugs (ANDA) | November 6, 2019 |
| Sun Pharmaceutical Industries, Inc. | 2 | injection, powder, lyophilized, for solution; injection | New drug applications (NDA) | June 30, 1987 |
| The Methodist Hospital Research Institute | 2 | injection, solution; injection | Generic drugs (ANDA) | July 9, 2021 |
| The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute | 2 | injection | Generic drugs (ANDA) | November 1, 2013 |
| Washington University School of Medicine | 2 | injection | Generic drugs (ANDA) | March 20, 2012 |
| Aphelion LLC | 1 | injection | New drug applications (NDA) | July 1, 2026 |
| Barbara Ann Karmanos Cancer Hospital | 1 | injection | Generic drugs (ANDA) | January 31, 2020 |
| Bracco Diagnostics Inc | 1 | injection, solution | New drug applications (NDA) | December 30, 1989 |
| Eli Lilly and Company | 1 | injection, solution | New drug applications (NDA) | June 1, 2012 |
| GE Healthcare Inc. | 1 | injection | New drug applications (NDA) | February 19, 2025 |
| GE Healthcare Inc. | 1 | injection | New drug applications (NDA) | May 20, 2020 |
| Iso-Tex Diagnostics, Inc. | 1 | injection, solution | New drug applications (NDA) | May 1, 1983 |
| Jubilant DraxImage Inc., DBA Jubilant Radiopharma | 1 | injection, solution | Generic drugs (ANDA) | November 20, 2010 |
| Jubilant Draximage (USA) Inc. | 1 | injection, powder, for solution | Generic drugs (ANDA) | July 1, 2009 |
| Kettering Medical Center | 1 | injection | Generic drugs (ANDA) | December 8, 2011 |
| Lantheus Biosciences Ltd., a Lantheus Company | 1 | injection, solution | New drug applications (NDA) | March 20, 2014 |
| Mips Cyclotron & Radiochemistry Facility | 1 | injection | Generic drugs (ANDA) | February 28, 2015 |
| Progenics Pharmaceuticals, Inc. | 1 | injection | New drug applications (NDA) | May 26, 2021 |
| The Johns Hopkins University | 1 | injection | Generic drugs (ANDA) | March 21, 2012 |
| The Regents of the University of Michigan | 1 | injection | Generic drugs (ANDA) | July 17, 2015 |
| The University of Texas Southwestern Medical Center | 1 | injection, solution | Generic drugs (ANDA) | May 1, 2020 |
| Trustees of the University of Pennsylvania | 1 | injection, solution | Generic drugs (ANDA) | October 30, 2014 |
| Uihc-P E T Imaging Center | 1 | injection | Generic drugs (ANDA) | December 12, 2011 |
| University of Wisconsin System | 1 | injection | Generic drugs (ANDA) | September 9, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 47 | 58% |
| Injection, solution | 27 | 33.3% |
| Injection, powder, lyophilized, for solution | 5 | 6.2% |
| Solution | 1 | 1.2% |
| Injection, powder, for solution | 1 | 1.2% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.